Ziping Qi
7Patents
0h-index
31Co-inventors
34Inventor score
Filing activity: Dec 15, 2016 → Oct 9, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10975082B2 | Inhibitor of FLT3 kinase and use thereof | Human Necessities | 0 | Active |
| US12318398B2 | MST1 kinase inhibitor and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10350210B2 | EGFR and ALK dual inhibitor | Emerging Cross-Sectional Technologies | 0 | Active |
| US12221448B2 | Selective PI3Kδ inhibitor and use thereof | Human Necessities | 0 | Active |
| US10781214B2 | Kinase inhibitor against wild-type and mutant EGFR | Human Necessities | 0 | Active |
| US10793543B2 | Selective C-KIT kinase inhibitor | Chemistry; Metallurgy | 0 | Active |
| US12162876B2 | Indazole kinase inhibitor and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.